Here, we sought to determine if the Akt/mammalian target of rapamycin (mTOR) pathway and the autophagic process play any specific role in the regulation of the anticancer properties of anthricin in breast cancer cell lines. The gene discussed is MTOR; the disease is breast carcinoma.